Skip to main content
Premium Trial:

Request an Annual Quote

John Hurrell Will Head Indiana Proteomics Consortium

NEW YORK, July 16-The Indiana Proteomics Consortium will be headed by longtime biotech manager John Hurrell, the consortium said yesterday.


Hurrell will help structure the new consortium by overseeing investigators and developing a management infrastructure.


He was most recently general manager of North Carolina's TriPath Oncology. Prior to that he was president and CEO of FluorRx, which he co-founded after leaving Boehringer Mannheim.


Indiana University, Purdue University and Eli Lilly jointly founded the consortium in February 2002 in order to develop new tools and techniques in proteomics.


Rick Ludwig, the consortium's interim director, will soon return to his work coordinating proteomics research at Lilly.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.